M E Bryan

Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, MA, United States.; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.; Broad Institute of MIT and Harvard, Cambridge, MA, United States.

31 publications 1966 – 2026 ORCID

What does M E Bryan research?

M E Bryan studies how to better detect and monitor cancers associated with human papillomavirus (HPV), especially those that affect the throat and head. Their research involves developing sensitive blood tests that can find traces of cancer DNA years before patients might typically receive a diagnosis. This is crucial for conditions that are often diagnosed late and can lead to significant health problems. Through their studies, they aim to improve early detection methods, allowing for timely treatments that can enhance survival rates and reduce unnecessary interventions for patients who may not need them.

Key findings

  • A blood test for HPV DNA can detect oropharyngeal cancer up to 10 years before diagnosis, significantly improving early detection possibilities.
  • Post-surgery blood tests showing traces of cancer DNA predict a 40% lower chance of remaining cancer-free in two years, compared to those without detectable DNA (60% vs 100%).
  • A new blood test identified 98.7% of HPV-related head and neck cancer cases accurately while also avoiding false alarms 98.7% of the time, outperforming four other existing tests.
  • Blood tests can detect about 79% of patients who might develop HPV-related throat cancer up to 10 years earlier than traditional detection methods.
  • Monitoring circulating tumor DNA can help tailor treatments, predicting treatment response and survival rates in patients with recurrent/metastatic head and neck cancer.

Frequently asked questions

Does Dr. Bryan study throat cancer?
Yes, Dr. Bryan focuses on HPV-related throat cancers and works on improving detection and monitoring of these conditions.
What treatments has Dr. Bryan researched?
Dr. Bryan's research primarily investigates blood tests to detect cancer presence and monitor treatment responses rather than specific therapies.
Is Dr. Bryan's work relevant to patients at risk of HPV-related cancers?
Absolutely, Dr. Bryan's studies aim to help patients at risk by enabling early detection and better monitoring of HPV-related cancers.
How does Dr. Bryan's research benefit patients?
By developing sensitive blood tests, Dr. Bryan's research offers the potential for earlier diagnosis, which can lead to better treatment outcomes and increased survival chances.
What is circulating tumor DNA and why is it important?
Circulating tumor DNA (ctDNA) consists of small fragments of cancer DNA found in the bloodstream. It is important because it helps predict treatment responses and cancer recurrence, allowing for more personalized patient care.

Publications in plain English

Human and viral whole genome sequencing identify HPV and APOBEC as oncogenic drivers in sinonasal squamous cell carcinoma.

2026

medRxiv : the preprint server for health sciences

Chong HB, Bryan ME, Lin M, Faquin WC, Mirabello L +4 more

Plain English
This study looked at a type of head and neck cancer called sinonasal squamous cell carcinoma (SNSCC) and found that certain strains of the human papillomavirus (HPV), including HPV45, 51, and 39, play a significant role in causing this cancer. Researchers discovered that these HPV strains contribute to the cancer by integrating DNA into the tumor and causing mutations that help the cancer grow. This is important because it shows that more than 80% of SNSCC cases may be linked to specific virus strains, which could change how doctors diagnose and treat this aggressive cancer. Who this helps: Patients with sinonasal squamous cell carcinoma.

PubMed

Circulating tumor human papillomavirus DNA whole genome sequencing enables human papillomavirus-associated oropharynx cancer early detection.

2026

Journal of the National Cancer Institute

Das D, Hirayama S, Aye L, Bryan ME, Naegele S +14 more

Plain English
Researchers developed a blood test that detects HPV cancer DNA years before oropharyngeal cancer (a common throat cancer) develops, finding the virus DNA in 79% of patient blood samples taken up to 7.8 years before diagnosis, while showing no false positives in healthy people. Using advanced computer analysis, they improved the test to detect the cancer signal in 96% of cases up to 10 years before symptoms appear. This discovery could enable doctors to catch this aggressive cancer much earlier, when treatment is more likely to succeed and causes less harm.

PubMed

De-siloing substance misuse and self-harm research through integrated public health and emergency medicine.

2025

The Lancet. Public health

Schölin L, Humphries C, Eddleston M, Brennan G, Lloyd A +4 more

Plain English
This research looks at how substance misuse and self-harm are connected to public health and emergency care. It reveals that people dealing with these issues often visit emergency departments more frequently and have a high risk of dying within a year after their treatment, with mortality rates between 5% and 15%. By combining public health and emergency medicine, the study stresses the need for better understanding and interventions that consider both social factors and personal experiences, which can lead to improved care and outcomes. Who this helps: This helps patients struggling with substance misuse and self-harm, as well as healthcare providers working in emergency settings.

PubMed

Ebola virus in Kasai revives 50-year-old questions on viral latency.

2025

Lancet (London, England)

Bryan ME, Nzanzu Vivalya BM, Geisbert TW, Judson SD, Munster V

PubMed

Molecular patterns and mechanisms of tumorigenesis in HPV-associated and HPV-independent sinonasal squamous cell carcinoma.

2025

Nature communications

Zamuner FT, Gunti S, Starrett GJ, Faraji F, Toni T +15 more

Plain English
This study looked at a rare type of cancer called sinonasal squamous cell carcinoma (SNSCC), specifically how it develops and how it differs when associated with the human papillomavirus (HPV). Researchers found that HPV-related SNSCC shares certain genetic mutations found in other HPV-related cancers and identified specific mutations that are linked to worse survival rates. They also discovered that blocking certain molecular pathways could potentially improve treatment for patients with HPV-associated SNSCC. Who this helps: This helps patients with HPV-associated sinonasal squamous cell carcinoma.

PubMed

Spatial characterization of tertiary lymphoid structures as predictive biomarkers for immune checkpoint blockade in head and neck squamous cell carcinoma.

2025

Oncoimmunology

Ruiz-Torres DA, Bryan ME, Hirayama S, Merkin RD, Luciani E +8 more

Plain English
This study examined how certain structures in the tumor called tertiary lymphoid structures (TLS) can help predict which patients with head and neck cancer will respond to a specific type of immunotherapy known as immune checkpoint blockade (ICB). Researchers looked at tumor samples from 20 patients, finding that those who responded to treatment had more B cells present and better survival rates when TLS were located close to the tumor. The study also showed that measuring TLS density could predict treatment response with 80% accuracy, suggesting it may be a better indicator than the currently used marker. Who this helps: This helps patients with recurrent head and neck cancer by improving treatment prediction and outcomes.

PubMed

Personalized circulating tumor DNA dynamics inform survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancer.

2025

NPJ precision oncology

Ruiz-Torres DA, Merkin RD, Bryan ME, Mendel J, Efthymiou V +11 more

Plain English
Researchers studied patients with a severe type of head and neck cancer that often comes back or spreads. They found that monitoring a specific marker in the blood, known as circulating tumor DNA (ctDNA), can help predict how well patients will respond to treatment and how long they might live. This is important because it offers a new way to tailor treatments to individual patients, potentially improving their chances of survival and minimizing side effects from ineffective therapies.

PubMed

Direct Comparison of Alternative Blood-Based Approaches for Early Detection and Diagnosis of HPV-Associated Head and Neck Cancers.

2025

Clinical cancer research : an official journal of the American Association for Cancer Research

Bryan ME, Aye L, Das D, Hirayama S, Al-Inaya Y +29 more

Plain English
Researchers developed a new blood test using advanced DNA sequencing to detect HPV-associated head and neck cancers early, before symptoms appear, and compared it to three other blood-based detection methods. The new sequencing test detected cancer 98.7% of the time it was present and correctly identified healthy people 98.7% of the time—significantly better than existing blood tests. This breakthrough matters because HPV-related head and neck cancers are becoming more common, yet doctors currently have no way to catch them early when treatment is most effective.

PubMed

Clinical validation of an HPV whole genome sequencing assay for molecular residual disease detection in HPV-associated head and neck cancer patients treated with surgery.

2025

medRxiv : the preprint server for health sciences

Hirayama S, Al-Inaya Y, Bryan ME, Das D, Aye L +19 more

Plain English
Researchers developed a highly sensitive blood test that detects tiny amounts of HPV cancer DNA left in patients after surgery for HPV-related head and neck cancer. They found that patients whose blood still contained this cancer DNA had much worse outcomes—only 60% stayed cancer-free for 2 years compared to 100% of patients with no detectable DNA—and this blood test was better at predicting who would relapse than current methods doctors use. The test could also spot cancer coming back up to 17 months before it shows up on scans or causes symptoms, giving doctors an early warning system to decide whether patients need additional treatment like chemotherapy or radiation.

PubMed

Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody induction.

2024

Cell host & microbe

Wiehe K, Saunders KO, Stalls V, Cain DW, Venkatayogi S +30 more

Plain English
Researchers aimed to develop vaccines that can effectively trigger the production of broadly neutralizing antibodies (bnAbs) against HIV-1. They found a way to design vaccines that successfully led to the creation of these antibodies in mice, particularly by enhancing unlikely genetic changes needed for stronger immune responses. This advancement is important because it represents a significant step toward creating a viable vaccine for HIV-1 that could protect a wide range of people from the virus. Who this helps: This helps patients at risk of HIV, as well as doctors involved in HIV treatment and prevention.

PubMed

Molecular patterns and mechanisms of tumorigenesis in HPV-associated and HPV-independent sinonasal squamous cell carcinoma.

2024

bioRxiv : the preprint server for biology

Zamuner FT, Gunti S, Starrett GJ, Faraji F, Toni T +15 more

Plain English
This research studied two types of sinonasal squamous cell carcinoma (SNSCC), one linked to human papillomavirus (HPV) and the other not. The study found that HPV is a key player in the development of HPV-associated tumors, and they identified specific mutations that are common in these cancers, including those in the PI3K and FGFR3 genes. Targeting certain pathways in these tumors could lead to better treatments, especially using a combination of drugs that block certain cancer-driving processes. Who this helps: This helps patients with HPV-associated sinonasal tumors.

PubMed

Immune Cell Densities Predict Response to Immune Checkpoint-Blockade in Head and Neck Cancer.

2024

medRxiv : the preprint server for health sciences

Ruiz-Torres DA, Bryan ME, Hirayama S, Merkin RD, Luciani E +8 more

Plain English
This study looked at how certain immune cells in head and neck cancer tumors can predict whether patients will respond well to a treatment called immune checkpoint blockade (ICB). The researchers found that patients who responded to ICB had a higher amount of B lymphocytes (CD20+ cells) in their tumors compared to those who did not respond (22% vs. lower levels). Additionally, certain structures called Tertiary Lymphoid Structures (TLS) near the tumors were linked to better survival rates, with a 4% higher chance of overall survival among patients with these structures. Who this helps: This research helps patients with head and neck cancer by identifying better predictors of treatment response.

PubMed

Blood-based screening for HPV-associated cancers.

2024

medRxiv : the preprint server for health sciences

Das D, Hirayama S, Aye L, Bryan ME, Naegele S +13 more

Plain English
Researchers developed a blood test that can detect a common cancer caused by HPV (the virus linked to cervical cancer) years before symptoms appear—up to 10 years early in some cases. The test works by finding tiny pieces of HPV DNA floating in the bloodstream, which the cancer releases long before the disease becomes noticeable. When they tested blood samples taken years before patients were actually diagnosed with cancer, the test caught 79% of future cancer cases while giving zero false alarms in healthy people. Using artificial intelligence to analyze the blood samples improved detection even further, catching 96% of cases. This matters because unlike cervical cancer, there's currently no screening test for this type of HPV-related throat cancer—the most common HPV cancer in America. A blood test that finds it a decade early could save lives by catching cancer when it's easiest to treat.

PubMed

Neutering is associated with developing hemangiosarcoma in dogs in the Veterinary Medical Database: An age and time-period matched case-control study (1964-2003).

2020

The Canadian veterinary journal = La revue veterinaire canadienne

Robinson KL, Bryan ME, Atkinson ES, Keeler MR, Hahn AW +1 more

Plain English
This study looked at whether neutering (spaying or castrating) dogs increases their risk of developing a type of cancer called hemangiosarcoma (HSA). Researchers found that spayed female dogs have a higher risk, with odds ratios of 1.59 for splenic HSA, 1.47 for cardiac HSA, and 1.72 for HSA overall, while castrated males have an odds ratio of 1.26 for splenic HSA and 1.14 for HSA overall compared to intact males. This matters because it raises awareness about the potential risks associated with neutering dogs, which could influence decisions about pet care. Who this helps: This helps pet owners and veterinarians make more informed choices about neutering.

PubMed

Clinical Evaluation of Tavocept to Decrease Diuresis Time and Volume in Dogs with Bladder Cancer Receiving Cisplatin.

2018

Journal of veterinary internal medicine

Henry CJ, Flesner BK, Bechtel SA, Bryan JN, Tate DJ +5 more

Plain English
This study looked at how a drug called Tavocept could help dogs with bladder cancer by reducing the time they need to undergo a process called diuresis, which is used to flush out the chemotherapy drug cisplatin from their system. When Tavocept was used, the time needed for diuresis dropped from over 6 hours to just 90 minutes, and only 21% of the dogs showed signs of kidney problems, which is lower than in dogs treated without Tavocept. While the overall response to treatment was 27% and the average survival time was about 253 days, which is similar to other dogs treated without Tavocept, this treatment approach could make chemotherapy safer for these dogs. Who this helps: This benefits dogs with bladder cancer and their veterinarians.

PubMed

Gum arabic-coated radioactive gold nanoparticles cause no short-term local or systemic toxicity in the clinically relevant canine model of prostate cancer.

2014

International journal of nanomedicine

Axiak-Bechtel SM, Upendran A, Lattimer JC, Kelsey J, Cutler CS +8 more

Plain English
This study looked at a new treatment for prostate cancer in dogs using tiny radioactive gold particles wrapped in a natural substance called gum arabic. After injecting these particles into nine dogs with prostate cancer, researchers found no serious side effects or toxic reactions, and about 53% of the treatment stayed where it was supposed to, in the prostate. This matters because it shows that this new treatment might be safe and effective, which is important for developing better cancer therapies. Who this helps: This benefits dogs with prostate cancer and their veterinarians.

PubMed

Effects of two training curricula on basic laparoscopic skills and surgical performance among veterinarians.

2012

Journal of the American Veterinary Medical Association

Fransson BA, Ragle CA, Bryan ME

Plain English
The study looked at how two different training programs affected the laparoscopic skills of 17 veterinarians. It found that the second training program (curriculum B) significantly improved the veterinarians' basic skills and overall surgical performance, while the first program (curriculum A) did not lead to any improvements. This matters because better training can enhance surgical outcomes for animals, leading to safer and more effective procedures. Who this helps: This helps veterinarians improve their surgical techniques and ultimately benefits animal patients.

PubMed

A laparoscopic surgical skills assessment tool for veterinarians.

2010

Journal of veterinary medical education

Fransson BA, Ragle CA, Bryan ME

Plain English
This study looked at how well veterinarians perform laparoscopic surgery by testing their skills in a simulated dog surgery. It found that the more years a veterinarian has performed certain laparoscopic procedures, the better their scores were on performance evaluations, with strong links to basic skills assessments. This is important because it helps identify effective training methods for veterinarians, ensuring higher surgical standards and better care for animals. Who this helps: This benefits veterinarians and ultimately their animal patients.

PubMed

Comparison of systemic toxicities of 177Lu-DOTMP and 153Sm-EDTMP administered intravenously at equivalent skeletal doses to normal dogs.

2009

Journal of nuclear medicine technology

Bryan JN, Bommarito D, Kim DY, Berent LM, Bryan ME +5 more

Plain English
This study tested a new drug called 177Lu-DOTMP on healthy dogs to see how toxic it is to their bodies. The dogs received a dose of about 8.14 MBq for each kilogram of their body weight and were monitored for 84 days. The researchers found no significant effects on blood counts or organ health, suggesting that the drug is well tolerated, which is important for its potential use in treating bone cancer in both dogs and humans. Who this helps: This helps patients with bone cancers, especially those in need of new treatment options.

PubMed

Effects of subanesthetic doses of ketamine on hemodynamic and immunologic variables in dogs with experimentally induced endotoxemia.

2008

American journal of veterinary research

DeClue AE, Cohn LA, Lechner ES, Bryan ME, Dodam JR

Plain English
This study looked at how low doses of ketamine affect blood pressure and immune response in dogs after they were given a substance that triggers a severe inflammatory reaction. The researchers found that while both ketamine and a saline solution reduced blood pressure over time, only the ketamine-treated dogs had a lower heart rate and lower peak levels of an immune marker called TNF-alpha. This is important because it shows that ketamine can help manage the immune response in dogs with inflammation, even if it doesn't significantly affect blood pressure or white blood cell counts. Who this helps: This research benefits veterinarians treating dogs with severe inflammatory conditions.

PubMed

Glucose lowering effects of inhaled insulin in healthy cats.

2008

Journal of feline medicine and surgery

DeClue AE, Leverenz EF, Wiedmeyer CE, Bryan ME, Reinero CR

Plain English
This study looked at how well inhaled insulin can lower blood sugar levels in healthy cats. The researchers tested different doses of inhaled insulin and found that the group receiving 25 units of inhaled insulin had significantly lower blood sugar levels compared to cats given saline or intravenous insulin, but more cats experienced low blood sugar episodes with the inhaled doses. These findings show that inhaled insulin can effectively reduce blood sugar in cats, which could lead to better management options for diabetic animals. Who this helps: This helps veterinarians and pet owners managing diabetic cats.

PubMed

A population study of neutering status as a risk factor for canine prostate cancer.

2007

The Prostate

Bryan JN, Keeler MR, Henry CJ, Bryan ME, Hahn AW +1 more

Plain English
This study looked at the link between being neutered and the risk of developing prostate cancer in male dogs. Researchers found that neutered male dogs were significantly more likely to develop various types of prostate cancer; for example, they were 8 times more likely to get prostate transitional cell carcinoma (TCC) compared to intact males. This is important because it highlights that neutering may increase cancer risk, which is crucial information for dog owners and veterinarians when making decisions about neutering. Who this helps: Dog owners and veterinarians making decisions about neutering male dogs.

PubMed

Erythema gyratum repens in a case of resolving psoriasis.

2003

Journal of drugs in dermatology : JDD

Bryan ME, Lienhart K, Smoller BR, Johnson SM

Plain English
This study looked at a rare skin condition called erythema gyratum repens (EGR) that sometimes occurs with cancer. The researchers reported a case where a patient with psoriasis, a common skin disease, developed EGR after being treated with a drug called acitretin. Understanding this connection is important because it helps doctors recognize EGR in patients who have psoriasis, even if they don't have cancer. Who this helps: This helps doctors and patients with psoriasis.

PubMed

Minocycline-induced immune thrombocytopenia presenting as Schamberg's disease.

2003

Journal of drugs in dermatology : JDD

D'Addario SF, Bryan ME, Stringer WA, Johnson SM

Plain English
This study looked at a case where a patient took minocycline, an antibiotic commonly used for acne, and developed a condition called drug-induced immune thrombocytopenic purpura (DITP), which caused tiny red spots on their legs resembling another skin condition known as Schamberg's disease. The patient's symptoms included small, non-blanching petechiae and distinctive macules on the lower legs, which were misidentified until the connection to the medication was made. This matters because it highlights a serious but uncommon side effect of a widely used antibiotic, improving awareness and diagnosis for others who might experience similar symptoms. Who this helps: This helps patients using minocycline and their doctors by providing crucial information about potential side effects.

PubMed

Radiation carcinogenesis in the Syrian hamster.

1979

Progress in experimental tumor research

Stenback WA, Bryan ME, Trentin JJ

PubMed

Vehicle noise and the passenger.

1978

Applied ergonomics

Bryan ME, Tempest W, Williams D

Plain English
This study looked at the noise levels inside cars and heavy vehicles and found that they are often too loud for passengers, especially at normal driving speeds. The research highlighted that low-frequency noises significantly impact how comfortable passengers feel, and it identified the need for clear standards on acceptable noise levels in vehicles. Establishing these standards is important for improving passenger comfort and safety during travel. Who this helps: This benefits passengers and vehicle manufacturers by creating a better travel experience.

PubMed

The application of ultrasound to audiometry.

1974

Biomedical engineering

Bryan ME, Nowell E

PubMed

The auditory threshold for short-duration pulses.

1971

The Journal of the Acoustical Society of America

Tempest W, Bryan ME

PubMed

Infrequent C-F antibody response in mice with adenovirus type 12 tumors.

1967

Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)

Van Hoosier GL, Trentin JJ, Chenault SS, Bryan ME, McCormick KJ

PubMed

Precision audiometry.

1967

Acta oto-laryngologica

Bryan ME, Tempest W

PubMed

Objective audiometry.

1966

The Journal of the Acoustical Society of America

Tempest W, Bryan ME

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.